Product
Peginterferon Lambda
1 clinical trial
1 indication
Indication
Hepatitis DClinical trial
Open Label Phase 2 Clinical Study of Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta HepatitisStatus: Withdrawn, Estimated PCD: 2024-05-22